Inflamm Bowel Dis 2008,

14:147–161 PubMedCrossRef 19 Gop

Inflamm Bowel Dis 2008,

14:147–161.PubMedCrossRef 19. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ: Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol 2006, 44:4136–4141.PubMedCrossRef 20. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J: Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 2006, 55:205–211.PubMedCrossRef 21. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y: Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009, BAY 63-2521 order 62:264–269.PubMedCrossRef 22. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA: Combination ARS-1620 datasheet of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990, 56:1919–1925.PubMed 23. Wallner G, Amann R, Beisker W: Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide

probes for flow cytometric PX-478 nmr identification of microorganisms. Cytometry 1993, 14:136–143.PubMedCrossRef 24. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling GW: Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995, 61:3069–3075.PubMed 25. Harmsen HJM, Elfferich P, Schut F, Welling GW: A 16S

rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridisation. Microbiol Ecol Health Dis 1999, 11:3–12.CrossRef 26. Manz W, Amann R, Ludwig W: Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiol 2006, 142:1097–1106. 27. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA: Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ selleck inhibitor hybridization. Infect Immun 1994, 62:5191–5194.PubMed 28. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW: Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64:3336–3345.PubMed 29. Suau A, Rochet V, Sghir A, Gramet G, Brewaeys S, Sutren M, Rigottier-Gois L, Doré J: Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 2001, 24:139–145.PubMedCrossRef 30.

Comments are closed.